Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia
about
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia
description
scientific article published on 16 July 2019
@en
name
Sorafenib plus intensive chemo ...... ositive acute myeloid leukemia
@en
type
label
Sorafenib plus intensive chemo ...... ositive acute myeloid leukemia
@en
prefLabel
Sorafenib plus intensive chemo ...... ositive acute myeloid leukemia
@en
P2093
P50
P356
P1433
P1476
Sorafenib plus intensive chemo ...... ositive acute myeloid leukemia
@en
P2093
Farhad Ravandi
Iman Abou Dalle
Keyur Patel
Musa Yilmaz
Naveen Pemmaraju
Prithviraj Bose
Sanam Loghavi
Sherry Pierce
P304
P356
10.1002/CNCR.32387
P50
P577
2019-07-16T00:00:00Z